ArticleMedical & biological engineering & computing2026
A coarse-to-fine machine-learning framework for identifying functional connectivity markers of cognitive impairment in Parkinson's disease.
Article in Medical & biological engineering & computing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundResting-state functional MRI (rs-fMRI) has been applied to investigate cognitive impairment (CI) in Parkinson's disease (PD). Nevertheless, reported functional connectivity (FC) alterations remain heterogeneous, partly due to reliance on linear analytical approaches and limited validation across datasets.
objectiveTo develop a machine-learning framework for identifying generalizable FC markers of CI in PD.
methodsRs-fMRI data were obtained from an online cohort (for model training) and an independent local cohort (for external validation) of individuals with PD. Subjects were stratified according to the presence of CI. All images were preprocessed using an identical pipeline to derive whole-brain FC. A coarse-to-fine feature selection strategy was implemented, combining a genetic algorithm for global feature reduction with sequential feature selection using leave-one-out cross-validation.
resultsIn the training dataset (n = 181), genetic algorithm-based selection reduced 13,366 ROI-pair features to 229, achieving an accuracy of 0.83. Subsequent sequential selection further reduced the feature set to 10 ROI pairs, improving accuracy to 0.92. In the validation dataset (n = 32), the classification accuracy was 0.88, with FC patterns showing lateralized cortical and cerebellar involvement.
conclusionThe proposed framework identifies interpretable signatures of rs-fMRI-based markers associated with CI in PD and demonstrates the generalizability.
Indexed as
Identifiers
42435273What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.